Training new researchers to develop treatments for Alzheimer's and related dementias
Training in Translational Research in Alzheimer's and Related Dementias (TRIAD)
This program is helping researchers learn how to turn lab discoveries into real treatments for Alzheimer's and related dementias, so they can better understand the disease and find new ways to help those affected.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10894189 on NIH RePORTER |
What this research studies
This program focuses on training researchers to bridge the gap between laboratory discoveries and clinical applications for Alzheimer's disease and related dementias. It supports both predoctoral and postdoctoral trainees who will learn from experienced mentors across various disciplines, including molecular biology, genetics, and clinical research. The training emphasizes understanding major risk factors for Alzheimer's, such as neuroinflammation and genetic influences, to foster innovative treatment approaches. By integrating diverse expertise, the program aims to cultivate a skilled workforce dedicated to advancing effective therapies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk for Alzheimer's disease or those diagnosed with related dementias.
Not a fit: Patients with unrelated neurological conditions or those not affected by Alzheimer's disease or related dementias may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for Alzheimer's disease and related dementias.
How similar studies have performed: Previous research has shown success in training programs that integrate multiple disciplines to address complex health issues, indicating a promising approach.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Van Eldik, Linda J — University of Kentucky
- Study coordinator: Van Eldik, Linda J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.